Controlled Substance Act

As the formal review process for rescheduling cannabis unfolds, industry players are closely watching its potential to transform the sector. With the DEA hearing delayed until early 2025 and a possible Trump presidency adding uncertainty, cannabis businesses are preparing for what rescheduling to...

The Drug Enforcement Administration (DEA) will hold its first hearing on December 2 to address the Biden administration’s proposal to reclassify marijuana from Schedule I to Schedule III under the Controlled Substances Act (CSA). The hearing, announced through a public advisory on November 26...

In a rarely seen legal battle unfolding in a DEA courtroom in Arlington, Virginia, the future of two key psychedelic research compounds, DOI and DOC, hangs in the balance. The DEA's move to classify the substances as Schedule I drugs has sparked fierce resistance from researchers, neuroscientists...

In a significant development for psychedelics research, a Drug Enforcement Administration (DEA) administrative law judge has rejected the agency's request to block key witnesses and evidence in an upcoming hearing. The case, set for November, challenges the DEA's proposed ban on two psychedelic...

The Drug Enforcement Administration (DEA) has unveiled new production quotas for Schedule I and II controlled substances, with a notable emphasis on boosting the supply of certain psychedelics for research purposes. As Marijuana Moment reported, among the substances marked for increased production...

A federal appeals court heard arguments on Monday in a case that could significantly impact access to psilocybin for terminally ill patients. As reported by Marijuana Moment, the case brought by Dr. Sunil Aggarwal and his Advanced Integrated Medical Science (AIMS) Institute, challenges the Drug...

This article was originally published on MG Magazine and appears here with permission. In 1988, a federal judge brashly ruled against the Reagan administration’s drug policy and declared cannabis fit for medical use. The controversial decision nearly reclassified marijuana under the...

In a pivotal moment for the American cannabis sector, the U.S. Department of Health and Human Services (HHS) has proposed a reclassification of cannabis to the DEA. This could shift cannabis from its current Schedule I status, bringing potential upheaval in the perception and market dynamics of the...

A legal resident who runs a state-legal cannabis dispensary and decides to apply for U.S. citizenship risks being denied, according to a recent ruling by a federal court of appeals. The 9th Circuit Court of Appeals determined that Maria Elena Reimers'...